Kent Snyder

Company Info


home » company information » management » kent snyder
Kent Snyder, Chief Executive Officer and Chairman of the Board of Directors, joined Senomyx in June 2003 and has served as Chief Executive Officer and as a member of our Board of Directors since that time. On September 24, 2013, Senomyx announced that Mr. Snyder will be retiring from the CEO position as of January 2, 2014. Mr. Snyder will continue to serve as the Chairman of the Company’s Board of Directors, a role he has held since May 2008. From June 2003 until September 2009 Mr. Snyder also served as our President, and since May 2008 Mr. Snyder has served as our Chairman of the Board of Directors.

Prior to joining Senomyx, from October 2001 to June 2003, Mr. Snyder was retired. From July 1991 to October 2001, Mr. Snyder held various marketing and sales management positions with Agouron Pharmaceuticals, Inc., a Pfizer company. Mr. Snyder's most recent position was President of Global Commercial Operations, and prior to that Mr. Snyder served as Senior Vice President of Commercial Affairs and Vice President of Business Development. Mr. Snyder is a member of the Board of Directors of Santarus, Inc., a publicly-held biopharmaceutical company, and VentiRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company. Mr. Snyder received his B.S. from the University of Kansas and his M.B.A. from Rockhurst College.

back to Management

Home | Company Info | Flavor Programs | Direct Sales | News
Investor Relations | Careers | Contact | Site Map
© 2004-2015 Senomyx, Inc.
Copyright | Privacy